Financial losses and legal issues make Newsmax a risky investment.

Newsmax (NYSE: NMAX), the conservative media company that promotes itself as an alternative to Fox (NASDAQ: FOX) News and ...

The conservative-leaning media outlet went public on March 31 at an IPO price of $10 per share, skyrocketing 2,550% to a high of $265 by the next day. Here's what you need to know before rushing ...

Was that pop deserved? At this point, we have to consider that the post-IPO share price pop may be an anomaly for Newsmax. Prominence and novelty only go so far, and these days, it looks like that ...

Newsmax has a history of producing losses, however. Last year, the company lost $72.2 million compared to losses of $30.4 million and $41.8 million in 2022 and 2023, respectively.

It’s partly why investors clamored to get into Newsmax's IPO, sending the stock soaring well above its $10.00 per share IPO price. Shares are still trading above the company's IPO price as of ...

Newsmax stock stabilizes at $23 post-IPO surge. Strong 2024 revenue growth from subscriptions and fees highlights potential, but dilution may pose challenges. Read more on NMAX stock.

Newsmax faces audience limits, legal risks, and weak profit potential despite a strong cash position and loyal base. Find out why NMAX stock is a sell.

Newsmax is only 24.2% above its IPO price as of Friday. Shares of digital health firm Omada Health Inc. finished last week down 10% from its IPO price despite debuting up 21.1% on June 6.

The company's stock is down more than 90% from its peak post IPO. Despite this, it still remains expensive in my view. There isn't a direct catalyst today, so here's a quick analysis of the ...

Following the breakout year for Newsmax in 2024, leading up to the recent IPO, its main challenge will be maintaining rapid audience growth while navigating a highly competitive media landscape.